Manejo renal de urea y glucosa

Name: Manejo renal de urea y glucosa
Uploaded: 2021-05-06T00:53:23.000Z
Duration: 48 min 35 s

Renal Management of Urea and Glucose

Overview of Urea in Renal Physiology

The discussion begins with the importance of urea as a key metabolite in renal physiology, particularly in waste elimination from protein consumption.

Urea production ranges from 2.5 to 6,000 molars per day, derived from protein metabolism; clinically relevant metrics include blood urea nitrogen levels between 7 and 18 mg/dL.

Filtration and Reabsorption Mechanisms

Urea is filtered completely (100%) at the convoluted tubule, with approximately 50% reabsorbed back into circulation.

Initial reabsorption occurs at the proximal convoluted tubule, reducing urea concentration by half before it enters the loop of Henle.

Secretion and Concentration Mechanisms

A significant secretion of urea occurs in the thin loops of Henle, contributing to urine concentration mechanisms through countercurrent exchange.

This process can lead to a net increase in filtered urea within the tubules up to about 110% after initial filtration and subsequent secretion.

Differences Between Nephron Types

Medullary nephrons differ from superficial nephrons regarding urea transport due to their interaction with vasa recta, affecting how urea is secreted or absorbed.

In superficial nephrons, important changes occur primarily at the thin ascending portion of the loop.

Role of Collecting Duct and Hormonal Influence

The collecting duct plays a crucial role where approximately 70% of remaining urea is reabsorbed; this process is sensitive to antidiuretic hormone (ADH).

The complex cycle includes proximal reabsorption followed by secretion in the loop and final reabsorption influenced by ADH.

Transport Pathways for Urea

At the proximal tubule level, urea reabsorption mainly occurs via paracellular pathways as water absorption increases.

Specific transporters like UT-A2 facilitate movement from interstitial space into cells and then into tubular fluid during secretion processes.

Final Reabsorption Insights

In medullary nephrons' descending thin loops, similar facilitated secretion mechanisms are expected for effective recycling of urea.

Understanding Urea and Glucose Handling in the Kidneys

Urea Management in the Kidneys

The kidneys favor the reabsorption of approximately 70% of urea, leading to a secretion of about 40% of urea. This indicates a complex renal management system for urea.

Urea excretion is directly proportional to urinary flow; higher urinary flow results in increased urea expression. However, this relationship has limits at certain levels.

At a typical urinary flow rate of 1.5 liters per day, urea expression increases but eventually saturates, highlighting that urea excretion aligns with urinary flow rates.

Clinically, blood urea nitrogen (BUN) can indicate effective circulating volume changes. Decreases in effective circulating volume may not always correlate with significant glomerular filtration rate (GFR) changes.

A BUN-to-creatinine ratio greater than 10 suggests a notable loss of effective circulating volume since lower effective volume leads to increased blood urea nitrogen levels.

Glucose Handling by the Kidneys

Glucose management by the kidneys is crucial, especially regarding advancements in diabetes mellitus treatment related to renal glucose handling mechanisms.

Two key transporters involved in glucose handling are SGLT1 and SGLT2; SGLT1 has high affinity but low capacity while SGLT2 has low affinity but high capacity for glucose transport.

The filtered proportion of glucose closely approaches 1, indicating it is freely filtered like sodium and will be absorbed primarily at the proximal convoluted tubule (PCT).

In the PCT, glucose absorption occurs differentially across segments; SGLT2 transporter predominates initially for rapid glucose uptake alongside sodium.

Understanding Renal Glucose Transport and Diabetes

Overview of Renal Glucose Transport Mechanisms

High glucose concentrations are primarily reabsorbed in the proximal tubule, involving SGLT1 and SGLT2 transporters which play crucial roles in this process.

The cardinal signs of diabetes mellitus include polydipsia (increased thirst), polyphagia (increased appetite), and polyuria (increased urinary volume). These symptoms indicate uncontrolled diabetes.

Uncontrolled diabetes leads to extremely high glucose levels, often indicating a long-standing condition. This asymptomatic nature of diabetes can result in severe complications when symptoms manifest.

Mechanism Behind Polyuria in Diabetes

Polyuria occurs due to saturation of renal glucose transport; excess glucose is excreted when the transport capacity is overwhelmed.

The relationship between filtered load and reabsorption is illustrated by a glucose titration curve, showing how reabsorption decreases as glucose concentration increases beyond a threshold.

Understanding the Glucose Titration Curve

The filtered load remains constant regardless of glucose concentration until it reaches approximately 200 mg/dL, where reabsorption begins to decline due to transporter saturation.

Beyond 200 mg/dL, the curves for filtered load and reabsorbed load diverge, indicating that not all filtered glucose can be reabsorbed as SGLT1 and SGLT2 become saturated.

Normal blood glucose levels range from 70 to 100 mg/dL; values above 200 mg/dL signify impaired reabsorption capabilities leading to increased excretion.

Consequences of Saturated Glucose Transport

At saturation points (350–400 mg/dL), no additional glucose is reabsorbed; all excess is excreted. This phenomenon explains why individuals with uncontrolled diabetes experience significant polyuria.

The slope of the excretion line closely matches that of filtration at high concentrations, emphasizing that nearly all filtered loads are lost through urine once saturation occurs.

Osmotic Diuresis and Its Implications

High levels of unabsorbed glucose lead to osmotic diuresis, causing substantial water loss which may result in dehydration during hypoglycemic crises due to concurrent fluid loss alongside glucosuria.

SGLT2 Inhibitors: A Revolution in Diabetes and Kidney Disease Treatment

Introduction to SGLT2 Inhibitors

SGLT2 inhibitors are a new class of medications used for diabetes management, promoting glucosuria (glucose excretion in urine).

These drugs not only facilitate glucose loss but also reduce overall fluid volume, contributing to cardiovascular health.

They have shown potential in decreasing cardiovascular mortality and slowing the progression of kidney disease associated with diabetes.

Mechanism of Action

The inhibition of glucose reabsorption via SGLT2 does not lead to hypoglycemia because SGLT1 continues to function, maintaining some level of glucose reabsorption.

This mechanism allows for rapid glycemic control, especially beneficial for patients on additional insulin-sensitizing medications.

Impact on Endocrinology and Renal Physiology

The manipulation of renal glucose transport has significantly impacted both endocrinology and renal physiology fields.

Glucose transport primarily occurs through SGLT2; when its saturation is reached, it leads to glucosuria, which can cause osmotic diuresis and dehydration.

Pharmacological Insights

The pharmacological action involves inhibiting SGLT2 at the proximal tubule level; as one moves from segment 1 to segment 3 of the nephron, the expression levels of these transporters change.